BCL2L1 and ovarian cancer: Gene expression microarray analysis revealed that BCL2L1 is the most differentially expressed gene in chemotherapy‐resistant ovarian cancer cells compared with chemotherapy‐sensitive ovarian cancer cells, and the western blot results also prove that Bclxl, encoded by BCL2L1, is differentially expressed.